US Drug Recall Register
Class II · Moderate risk Terminated Initiated Dec 31, 2014 (12 years ago)

Virazole

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Non-Sterility: Valeant's laboratory observed a positive microbial contamination of Virazole lot 340353F, during testing at the 12 month stability pull.

What was recalled

Virazole (Ribavirin for Inhalation Solution, USP), Sterile Lyophilized For Administration by Aerosol Inhalation Only, Rx only, Contents: Four 6 g vials, 100 mL, Distributed by: Valeant Pharmaceuticals North America, Bridgewater, NJ 08807 USA, NDC 0187-0007-14.

Recalling firm
Valeant Pharmaceuticals North America LLC
NDC code
0187-0007-14
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0379-2015

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Ribavirin recalls

See all
Class II · Moderate risk Terminated

Ribavirin active pharmaceutical ingredient packaged in varying…

Reason Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Attix Pharmaceuticals D-879-2015
Class II · Moderate risk Terminated

Ribavirin

Reason Labeling:Label Mixup; RIBAVIRIN, Capsule, 200 mg may be potentially mislabeled as MODAFINIL, Tablet, 50 mg (1/2 of 100 MG Tablet), NDC 55253080130, Pedigree: AD21787_4, EXP: 5/1/2014; DESIPRAMINE HCL, Tablet, 50 mg, NDC 45963034302, Pedigree: AD30140_7, EXP: 5/7/2014.

Aidapak Services, LLC D-727-2014